{"database": "lobbying", "table": "lobbying_activities", "rows": [[3200437, "d7290961-f9cb-4cfd-8112-156aa06cccb7", "Q2", "HANCE SCARBOROUGH", 17443, "ALLIANCE FOR PHARMACY COMPOUNDING", 2024, "second_quarter", "PHA", "Issues related to the regulation of pharmacy compounding. Issues related to preserving patient access to compounded medications. Fiscal Year 2025 Appropriations HR167, the Patient Access to Urgent Use Compounded Medication Act", "HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2024-07-18T15:53:47-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3200437"], "units": {}, "query_ms": 38.68046903517097, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}